Womens Health

GLP-1 and Libido Changes in Women: What to Expect and How to Manage

If you've recently started a GLP-1 medication like semaglutide or tirzepatide and noticed changes in your sex drive, you're not alone. Many women report shifts in libido during their GLP-1 journey, but here's the interesting part: these changes can go either direction, and the reasons behind them are more complex than you might think.

Understanding what's happening in your body can help you feel more in control and know when to seek support.

How GLP-1 Medications Can Affect Libido

GLP-1 receptor agonists work by mimicking a natural hormone that regulates blood sugar and appetite. While these medications weren't designed to affect sexual function, they trigger a cascade of changes in your body that can indirectly influence your sex drive.

The relationship between GLP-1s and libido isn't simple cause-and-effect. Instead, it's influenced by multiple factors happening simultaneously as your body adjusts to the medication and experiences weight changes.

The Decrease in Libido: Why It Happens

Some women experience a temporary decrease in sex drive when starting GLP-1 therapy. Several factors contribute to this:

These factors are typically most pronounced in the first few months of treatment and often improve as your body adjusts.

The Increase in Libido: The Other Side of the Story

Interestingly, many women report an increase in sex drive after being on GLP-1 medications for several months. This improvement often relates to:

Gender Differences in GLP-1 and Sexual Function

While this article focuses on women's experiences, it's worth noting that men and women may experience different patterns with GLP-1 medications and libido.

Men more commonly report improvements in sexual function with GLP-1 therapy, likely due to better erectile function from improved cardiovascular health and blood sugar control. Women's libido is more closely tied to a complex interplay of hormones, emotional wellbeing, and physical comfort, making the response more variable.

Both men and women benefit from the metabolic improvements these medications provide, but the timeline and nature of sexual health changes can differ significantly.

What the Research Shows

Clinical research on GLP-1 medications and sexual function is still emerging, but early studies are promising.

Studies have shown that weight loss achieved through any method, including GLP-1 therapy, is associated with improvements in sexual function for many women, particularly those with obesity-related conditions like PCOS or metabolic syndrome.

The timing matters. Most women who experience initial decreases in libido see improvement after three to six months on therapy, once side effects subside and the benefits of metabolic improvement become more apparent.

Practical Tips for Managing Libido Changes

If you're experiencing changes in your sex drive while on GLP-1 therapy, these strategies can help:

Give It Time

Your body is undergoing significant changes. Many side effects, including those affecting libido, are temporary. Most women find that sexual desire stabilizes or improves after the initial adjustment period of three to four months.

Optimize Your Nutrition

Even though you're eating less, focus on nutrient density. Adequate protein, healthy fats, and micronutrients support hormone production. Don't cut calories too aggressively beyond what the medication naturally causes.

Stay Hydrated and Manage Side Effects

Dehydration and persistent nausea can dampen desire. Work with your healthcare provider to manage side effects effectively. Sometimes a dose adjustment makes all the difference.

Communicate with Your Partner

Open conversation about what you're experiencing can reduce pressure and maintain intimacy in other ways while your body adjusts. Your partner can be your greatest support during this transition.

Track Your Patterns

Keep notes about when you feel better or worse. This can help you and your healthcare provider identify whether the changes are medication-related, dose-dependent, or connected to other factors.

When to Talk to Your Healthcare Provider

While some fluctuation in libido is normal during GLP-1 therapy, certain situations warrant a conversation with your doctor:

Your healthcare provider can evaluate whether dose adjustment, additional support, or screening for other factors might be helpful.

The Bottom Line

Changes in libido while taking GLP-1 medications are common and usually temporary. For most women, any initial decrease in sex drive is outweighed by longer-term improvements in sexual function, confidence, and overall wellbeing as metabolic health improves.

Remember that your experience is valid, whether you notice an increase, decrease, or no change at all. Sexual health is an important component of overall wellness, and it deserves attention and support throughout your GLP-1 journey.

From the Ozari Care Team

We encourage our patients to view the first three to four months on GLP-1 therapy as an adjustment period for their entire system, including sexual health. If you're experiencing libido changes, focus on managing side effects, maintaining good nutrition despite reduced appetite, and giving your body time to adapt. Most patients find that sexual function stabilizes or improves once they're past the initial adjustment phase and experiencing the metabolic benefits of treatment.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically Reviewed — Ozari Clinical Content Team (OCCT). Health writers and wellness professionals specializing in GLP-1 therapy, metabolic health, and weight loss medicine. Content reviewed in accordance with Ozari's Editorial Standards. Last reviewed: April 25, 2026.

This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.

Last reviewed: April 25, 2026